Skip to main content
WeightCited

Berberine 관련 Insulin Resistance

A

Meta-analysis of 27 RCTs found significant improvements in fasting glucose, HbA1c, and insulin sensitivity. AMPK activation is comparable to metformin. A landmark RCT (n=116) showed 500 mg 3x/day reduced body weight by 3.6 kg and triglycerides by 35.9%.

<\/script>\n
`; }, get iframeSnippet() { const domain = 'weightcited.com'; const params = 'ingredient\u003Dberberine\u0026condition\u003Dinsulin\u002Dresistance'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

A

결론

Meta-analysis of 27 RCTs found significant improvements in fasting glucose, HbA1c, and insulin sensitivity. AMPK activation is comparable to metformin. A landmark RCT (n=116) showed 500 mg 3x/day reduced body weight by 3.6 kg and triglycerides by 35.9%.

Key Statistics

27

연구

2500

참여자

Positive

A

등급

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

일반적으로 사용되는 용량

general:
500 mg 2-3x/day with meals
starting:
500 mg/day and titrate
metabolicsupport:
1,000-1,500 mg/day

상한량: 1,500 mg/day; GI side effects limit intake; potential drug interactions

권장 복용 시간: With meals (reduces GI discomfort and synchronizes with postprandial glucose metabolism)

Safety & Side Effects

보고된 부작용

  • Diarrhea
  • Constipation
  • Flatulence
  • Abdominal pain
  • Potential hypoglycemia (when combined with diabetes medications)

알려진 상호작용

  • Diabetes medications (may potentiate — hypoglycemia risk)
  • CYP3A4 substrates (berberine is a CYP3A4 inhibitor)
  • CYP2D6 substrates
  • Cyclosporine
  • Metformin (additive effects)

일일 최대 섭취 허용량: 1,500 mg/day; GI side effects limit intake; potential drug interactions

건강기능식품을 복용하기 전에 반드시 의료 전문가와 상담하십시오.

Frequently Asked Questions

Does Berberine help with Insulin Resistance?
Based on 27 studies with 2,500 participants, there is strong evidence from multiple clinical trials that Berberine may support Insulin Resistance management. Our evidence grade is A (Strong Evidence).
How much Berberine should I take for Insulin Resistance?
Studies have used various dosages. A commonly studied range is 500 mg 2-3x/day with meals. Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of Berberine?
Reported side effects may include Diarrhea, Constipation, Flatulence, Abdominal pain. Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for Berberine and Insulin Resistance?
We rate the evidence as Grade A (Strong Evidence). This rating is based on 27 peer-reviewed studies with 2,500 total participants. The overall direction of effect is positive.

Related Evidence

FDA 면책 조항: 이 내용은 미국 식품의약국(FDA)의 평가를 받지 않았습니다. 이 웹사이트의 제품 및 정보는 질병의 진단, 치료, 완치 또는 예방을 목적으로 하지 않습니다. 제시된 근거 등급은 발표된 동료 심사 연구에 대한 우리의 분석에 기반하며, 의학적 조언을 구성하지 않습니다. 건강기능식품 복용을 시작하기 전에 반드시 의료 전문가와 상담하십시오.